% | $
Quotes you view appear here for quick access.

Protalix BioTherapeutics, Inc. (PLX) Message Board

  • robbie1165 robbie1165 Jul 29, 2013 5:23 PM Flag

    Rare dieases, hmmmm...

    Pfizer to Reorganize Into 3 Business Segments

    By Dan Radovsky | More Articles | Save For Later
    July 29, 2013 | Comments (0)

    Pfizer (NYSE: PFE ) plans to internally separate its commercial operations into three separate business segments, the company announced today. Two of those segments will include what the company calls innovative business lines, and a third will include its value lines.

    One of the innovative segments will include products that cover several therapeutic areas, including inflammation and immunology, CV/metabolic, neuroscience and pain, rare diseases, and women's and men's health. Those products will have market exclusivity beyond 2015

0.620.00(-0.56%)Aug 25 4:00 PMEDT